Clinical Trials
11 trialsNCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT00177268 2025-12-30
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
University of Pittsburgh
Recruiting
NCT07021495 2025-08-19
SKINERGY
Leiden University Medical Center
Recruiting
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Unknown
NCT05222516 2023-08-08
Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD
OM Pharma SA
Phase 2 Terminated
NCT03738423 2022-06-10
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Regeneron Pharmaceuticals
Phase 2 Terminated
NCT03736967 2021-11-01
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Regeneron Pharmaceuticals
Phase 2 Terminated
NCT02780167 2019-05-02
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
Pfizer
Phase 2 Completed
NCT00129415 2015-05-22
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
University of Michigan
Phase 1/2 Terminated
NCT01745159 2014-08-05
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Astellas Pharma Inc
Phase 4 Completed
NCT01077882 2012-07-06
OnderHUIDs
University Hospital, Ghent
Phase 4 Completed